1. Home
  2. INAB vs MGIH Comparison

INAB vs MGIH Comparison

Compare INAB & MGIH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IN8bio Inc.

INAB

IN8bio Inc.

HOLD

Current Price

$1.38

Market Cap

14.2M

Sector

Health Care

ML Signal

HOLD

Logo Millennium Group International Holdings Limited

MGIH

Millennium Group International Holdings Limited

N/A

Current Price

$1.49

Market Cap

15.9M

ML Signal

N/A

Company Overview

Basic Information
Metric
INAB
MGIH
Founded
2016
1978
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Publishing
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
14.2M
15.9M
IPO Year
2020
2022

Fundamental Metrics

Financial Performance
Metric
INAB
MGIH
Price
$1.38
$1.49
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
70.9K
8.9K
Earning Date
05-06-2026
10-28-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.12
$1.11
52 Week High
$4.20
$4.84

Technical Indicators

Market Signals
Indicator
INAB
MGIH
Relative Strength Index (RSI) 40.39 54.09
Support Level $1.35 $1.40
Resistance Level $2.14 $1.53
Average True Range (ATR) 0.10 0.04
MACD -0.00 0.01
Stochastic Oscillator 33.33 50.56

Price Performance

Historical Comparison
INAB
MGIH

About INAB IN8bio Inc.

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cellular therapy product candidates and gamma-delta T cell engagers (TCEs) for cancer and autoimmune diseases. Gamma-delta T cells are a specialized population of T cells that possess properties. It has conducted two primary investigator-sponsored Phase 1 clinical trials evaluating its gamma-delta T cell technologies in cancer patients, which have both completed primary enrollment. INB-100 is assessing its DeltEx Allogeneic (Allo) gamma-delta T cell therapy in adult patients with high-risk leukemias undergoing haploidentical stem cell transplantation (HSCT). It operates in a single segment.

About MGIH Millennium Group International Holdings Limited

Millennium Group International Holdings Ltd supplies paper-based packaging solutions, including inner packaging boxes produced with offset or flexo printing and outer corrugated boxes used for transportation, storage, pallets, and point-of-purchase displays. The company manufactures corrugated products of different sizes, shapes, thicknesses, and strengths according to customer specifications. It also operates a supply chain management business in Vietnam to service international clients who source their packaging needs from Vietnam and other ASEAN countries. The corrugated paper is durable, versatile, economical, and lightweight.

Share on Social Networks: